Blackstone and alnylam enter into $2 billion strategic financing collaboration

Blackstone and alnylam enter into $2 billion strategic financing collaboration to accelerate the advancement of rnai therapeutics.blackstone group inc - deal is anchored by blackstone's purchase of 50 percent of royalties owed to alnylam on global sales of inclisiran.blackstone group inc - transaction is also comprised of $100 million purchase of alnylam common stock.blackstone group - alnylam, an existing tenant of biomed realty, is also in discussions with biomed to expand its footprint in cambridge, ma.blackstone - deal also comprised of $1 billion in committed payments to acquire 50% of alnylam's royalties, commercial milestones for inclisiran.blackstone group inc - transaction is also comprised of up to $750 million in a first lien senior secured term loan led by gso.
ALNY Ratings Summary
ALNY Quant Ranking